- Home
- MGRX vs CNSP Comparison
MGRX vs CNSP Comparison
Compare MGRX & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRX
- CNSP
- Stock Information
- Founded
- MGRX 2021
- CNSP 2017
- Country
- MGRX United States
- CNSP United States
- Employees
- MGRX N/A
- CNSP N/A
- Industry
- MGRX Computer Software: Prepackaged Software
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- MGRX Technology
- CNSP Health Care
- Exchange
- MGRX Nasdaq
- CNSP Nasdaq
- Market Cap
- MGRX 5.8M
- CNSP 5.4M
- IPO Year
- MGRX 2023
- CNSP 2019
- Fundamental
- Price
- MGRX $2.32
- CNSP $0.11
- Analyst Decision
- MGRX
- CNSP Strong Buy
- Analyst Count
- MGRX 0
- CNSP 1
- Target Price
- MGRX N/A
- CNSP $0.50
- AVG Volume (30 Days)
- MGRX 174.3K
- CNSP 41.4M
- Earning Date
- MGRX 11-26-2024
- CNSP 11-15-2024
- Dividend Yield
- MGRX N/A
- CNSP N/A
- EPS Growth
- MGRX N/A
- CNSP N/A
- EPS
- MGRX N/A
- CNSP N/A
- Revenue
- MGRX $755,000.00
- CNSP N/A
- Revenue This Year
- MGRX N/A
- CNSP N/A
- Revenue Next Year
- MGRX N/A
- CNSP N/A
- P/E Ratio
- MGRX N/A
- CNSP N/A
- Revenue Growth
- MGRX 52.20
- CNSP N/A
- 52 Week Low
- MGRX $2.10
- CNSP $0.10
- 52 Week High
- MGRX $16.80
- CNSP $137.50
- Technical
- Relative Strength Index (RSI)
- MGRX 38.47
- CNSP 37.06
- Support Level
- MGRX $2.26
- CNSP $0.10
- Resistance Level
- MGRX $2.51
- CNSP $0.13
- Average True Range (ATR)
- MGRX 0.17
- CNSP 0.02
- MACD
- MGRX 0.05
- CNSP 0.00
- Stochastic Oscillator
- MGRX 44.00
- CNSP 8.50
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.